I Hate Entropy — A Reflection on Parkinson's
Where an attempt to stop Parkinson's actually ended
A Category Problem, Not a Target Problem
Infection, genetic, autoimmune, cancer — each has a methodology. Parkinson's has none, because there is no enemy to kill. It is cells wearing out. 60 years of treating wear-and-tear like infection has produced no disease-modifying drug.
Five Attempts, Structural Failure
Force more dopamine (levodopa — masks symptoms), ration dopamine (isradipine, failed), port the Alzheimer circuit-preservation method (doesn't fit single-point damage), refold the misfolded protein (beyond current tech), prodromal vaccine (too early, barriers uncross). Each failed for a different structural reason.
Entropy, Time, Aging — One Face
Physics defines time's direction by entropy. Biology expresses entropy as aging. Neurodegenerative diseases are localized accelerations of the same law. Parkinson's isn't a Parkinson's problem — it's an aging-biology problem. Parts wait for the whole.
Stopping Is Not the Only Contribution
Entropy wins eventually. But when is negotiable. Fifteen years of independence vs. thirty years is not the same disease. Extending the patient's own life is a meaningful contribution even when the disease cannot be stopped.
A Fifth Axis: External Bypass
Existing axes — drugs (levodopa), surgery (DBS), rehab (LSVT BIG), cell therapy (stem cells) — all try to fix what's inside. The fifth axis is external: read movement intent at the cervical spine, let distributed joint units execute it. Disease progression is irrelevant to the device's function.
Cervical BCI Phase 5 — Motion Disorder Bypass
Phase 1-4 of the cervical BCI (from the separate BCI essay) target healthy convenience. Phase 5 turns the same technology to patient independence. EMG intent 100-300ms before actual movement, decoded on phone, BLE to wrist/hip/ankle units. Same principle extends to ALS, spinal injury, post-stroke recovery.
